Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...

SPONSORED – Neuropathy affects ... problem without getting to the root cause. Health From Within Chiropractic has a better solution that does not involve drugs or surgery. Hear more about ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

Find Therapeutics, clinical-stage biopharmaceutical company, announced initiation of dosing in its phase 1 clinical study of FTX-101 in healthy volunteers. FTX-101 is a first-in-class therapeutic ...

manufacture and commercialise the drug in India. India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a major one. Diabetic ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be Presented at the Pain Therapeutics Summit in BostonMIAMI, FL ...

In March 2023, my 94-year-old mother had a shingles episode on the right side of her neck, head, ear and (to a lesser degree) right cheek. The ...

The Phase 1b/2 trial (ASIST study; NCT05322590) is currently underway evaluating BXQ-350 in combination with the standard of care in newly diagnosed patients with mCRC.

Investigational New Drug (IND) application for its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...